Júlia Perera-Bel

11PUBLICATIONS
123CO-AUTHORS
PharmacogenomicsInnate immunityPredictive and prognostic markersMolecular targetsEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 27, 2026
Integrating Genetic Variants and Expression Profiles of Pharmacogenes to Investigate Resistance to Antidepressant Treatment.

|Apr 24, 2026
IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.

|Jan 01, 2026
Immunosuppressive macrophages determine the effect of cellular senescence on tumor progression.

Marta Lalinde-Gutiérrez, Sandra Pérez-Ramos, Verónica Rodilla

|Nov 06, 2025
PRKG1 hinders myogenic differentiation and predicts response to AKT inhibitor ipatasertib in Rhabdomyosarcoma.

Estela Prada, Pablo Táboas, Evelyn Andrades

|Oct 24, 2025
EWS::FLI1 expression in human embryonic mesenchymal stem cells leads to transcriptional reprograming, defective DNA damage repair and Ewing sarcoma.

Inmaculada Hernández-Muñoz, Irene Cuervas, Estela Prada

|Feb 20, 2025
Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts.

Lilian Marie Boll, Sergio Vázquez Montes de Oca, Marta E Camarena

Pageof 2

Frequent Collaborators

4 joint publications

Pau Berenguer-Molins

3 joint publications

Joaquim Bellmunt

2 joint publications

Roser Tachó-Piñot

2 joint publications

Josep Lloreta-Trull